Systemic Inflammatory Response to CCRE

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

August 6, 2019

Study Completion Date

August 6, 2019

Conditions
Healthy
Interventions
DRUG

CCRE

Endotoxin challenge: Subjects will undergo inhalation of 20,000 EU CCRE. The CCRE will be inhaled by subjects as a nebulized preparation using an ultrasonic nebulizer until the challenge solution is completely spent (generally 10 minutes).

Trial Locations (1)

27599

Environmental Protection Agency Human Studies facility, Chapel Hill

All Listed Sponsors
collaborator

Environmental Protection Agency (EPA)

FED

lead

University of North Carolina, Chapel Hill

OTHER

NCT02847247 - Systemic Inflammatory Response to CCRE | Biotech Hunter | Biotech Hunter